Atlas Trials

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Clinical trial NCT04513912 · COMPLETED

Trial details

NCT number
NCT04513912
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2020-09-15
Primary completion
2023-10-03
Enrollment
757

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.